NO881661L - Humane rhinoviruspeptider. - Google Patents

Humane rhinoviruspeptider.

Info

Publication number
NO881661L
NO881661L NO881661A NO881661A NO881661L NO 881661 L NO881661 L NO 881661L NO 881661 A NO881661 A NO 881661A NO 881661 A NO881661 A NO 881661A NO 881661 L NO881661 L NO 881661L
Authority
NO
Norway
Prior art keywords
acid residues
human rhinovirus
amino acid
peptides
hbv
Prior art date
Application number
NO881661A
Other languages
English (en)
Norwegian (no)
Other versions
NO881661D0 (no
Inventor
Michael James Francis
Berwyn Ewart Clarke
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10616016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO881661(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO881661D0 publication Critical patent/NO881661D0/no
Publication of NO881661L publication Critical patent/NO881661L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO881661A 1987-04-16 1988-04-15 Humane rhinoviruspeptider. NO881661L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709274A GB8709274D0 (en) 1987-04-16 1987-04-16 Peptides

Publications (2)

Publication Number Publication Date
NO881661D0 NO881661D0 (no) 1988-04-15
NO881661L true NO881661L (no) 1988-10-17

Family

ID=10616016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881661A NO881661L (no) 1987-04-16 1988-04-15 Humane rhinoviruspeptider.

Country Status (14)

Country Link
EP (1) EP0287395B1 (de)
JP (1) JP2925118B2 (de)
AT (1) ATE98962T1 (de)
AU (1) AU605574B2 (de)
CA (1) CA1340926C (de)
DE (1) DE3886443T2 (de)
DK (1) DK204588A (de)
ES (1) ES2060650T3 (de)
GB (1) GB8709274D0 (de)
IE (1) IE62382B1 (de)
NO (1) NO881661L (de)
NZ (1) NZ224251A (de)
PT (1) PT87239B (de)
ZA (1) ZA882641B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903313D0 (en) * 1989-02-14 1989-04-05 Wellcome Found Conjugates
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses
DE102009053588A1 (de) 2009-11-17 2011-05-19 Teijin Monofilament Germany Gmbh Abriebbeständige Monofilamente
DE202012001985U1 (de) 2012-02-25 2012-03-30 Nextrusion Gmbh Abriebbeständige Monofilamente für Papiermaschinenbespannungen
EP4378951A1 (de) * 2021-07-26 2024-06-05 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Epitoppolypeptid mit allgemeiner affinität für humanes rhinovirus sowie antikörper und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
JPS6147191A (ja) * 1984-07-20 1986-03-07 メルク　エンド　カムパニー　インコーポレーテッド ヒト・ライノウイルスｒｎａおよびたんぱく
DE3505148A1 (de) * 1985-02-15 1986-10-30 Boehringer Ingelheim International GmbH, 6507 Ingelheim Polypeptide des rhinovirusstammes hrv2 sowie die hierfuer codierenden dna-molekuele
GB8821077D0 (en) * 1988-09-08 1988-10-05 Wellcome Found Peptides

Also Published As

Publication number Publication date
AU1464488A (en) 1988-10-20
JPS6456695A (en) 1989-03-03
DK204588A (da) 1988-10-17
IE62382B1 (en) 1995-01-25
NO881661D0 (no) 1988-04-15
EP0287395B1 (de) 1993-12-22
ATE98962T1 (de) 1994-01-15
EP0287395A1 (de) 1988-10-19
GB8709274D0 (en) 1987-05-20
ZA882641B (en) 1988-09-30
ES2060650T3 (es) 1994-12-01
PT87239B (pt) 1992-08-31
JP2925118B2 (ja) 1999-07-28
DK204588D0 (da) 1988-04-14
CA1340926C (en) 2000-03-14
NZ224251A (en) 1991-09-25
DE3886443T2 (de) 1994-05-26
DE3886443D1 (de) 1994-02-03
AU605574B2 (en) 1991-01-17
PT87239A (pt) 1988-05-01
IE881140L (en) 1988-10-16

Similar Documents

Publication Publication Date Title
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
GB2255093A (en) Hiv-1 core protein fragments
SE8205313L (sv) Antigen-proteinkomplex for blockering av allergiska reaktioner samt sett for framstellning derav
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
ATE134195T1 (de) Peptidfragmente von hiv
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
NO881661L (no) Humane rhinoviruspeptider.
DK0412766T3 (da) Peptidfragmenter af HIV
DK0426314T3 (da) HIV-relaterede peptider
YU64192A (sh) Analozi insulina
FI910587A0 (fi) Syntetiska polypeptider och antikroppar, vilka haenfoer sig till epstein-barr-virusets nukleaera antigen.
DE68920735D1 (de) Peptide die vom Maul- und Klauenseuchevirus stammen.
SE8701294L (sv) Hiv-peptid
DK119391A (da) Humaninsulinanaloger